A new clinical trial investigating the efficacy of electroacupuncture in treating Post-Stroke Cognitive Impairment (PSCI) is set to begin recruitment. The study, backed by prominent institutions in China, will explore whether this traditional technique offers meaningful improvements for individuals affected by PSCI.
What changed?
A new clinical trial focusing on electroacupuncture as a potential treatment for Post-Stroke Cognitive Impairment (PSCI) has been announced. The study has not yet commenced recruitment but may offer valuable insights into alternative therapies for managing cognitive impairment following a stroke. Stakeholders in the clinical, regulatory, and medical device sectors should pay close attention to the trial’s progress and outcomes for potential advances in treatment strategies.
What is being studied?
The trial investigates the use of electroacupuncture, a treatment methodology that integrates traditional acupuncture techniques with electrical stimulation. Specifically, the study aims to evaluate its impact on cognitive recovery in patients suffering from PSCI, a condition that affects memory, attention, and problem-solving skills after a stroke.
Post-stroke cognitive decline remains a significant unmet medical need, often severely affecting patients’ quality of life. By exploring the potential of electroacupuncture, this study bridges a gap between traditional Chinese medicine and modern medical research. If proven effective, the intervention could provide an accessible alternative for enhancing rehabilitation outcomes post-stroke.
Who is involved?
The clinical trial is spearheaded by Ruijie Ma in collaboration with several respected healthcare organizations, including:
- The Second Affiliated Hospital, School of Medicine, Zhejiang University
- The Third Affiliated Hospital of Zhejiang Chinese Medical University
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Hangzhou Hospital of Traditional Chinese Medicine
- Zhejiang Provincial People’s Hospital
These institutions collectively contribute extensive expertise in both traditional Chinese medicine and modern medical research, ensuring a robust and comprehensive study design.
FAQs
1. What is the purpose of this trial?
This trial aims to evaluate the use of electroacupuncture in improving cognitive function in patients affected by PSCI, a condition that can significantly impact quality of life after a stroke.
2. Who is sponsoring the study, and where is it based?
The study is sponsored by Ruijie Ma and supported by various institutions in China, including hospitals affiliated with Zhejiang University and Zhejiang Chinese Medical University. Recruitment has not yet started.
3. What is electroacupuncture?
Electroacupuncture is a technique combining traditional acupuncture with electrical stimulation for therapeutic purposes. It is believed to enhance the effects of conventional acupuncture.
4. When will recruitment for this study begin?
No specific start date for recruitment has been provided, but interested parties can follow updates on ClinicalTrials.gov.
5. How can I access more information?
Additional details, including updates on recruitment status, can be found on the official ClinicalTrials.gov website linked below.
Conclusion
This upcoming clinical trial could provide critical insights into the effectiveness of electroacupuncture in managing post-stroke cognitive impairment. Regulatory teams, clinicians, and stakeholders in the medical device industry should monitor this study for its potential contributions to the treatment of PSCI. For further updates, refer to the official ClinicalTrials.gov page linked below.
Disclaimer
This article is intended for informational purposes only and does not constitute legal or clinical advice. Stakeholders should consult regulatory guidelines and professionals for specific compliance requirements.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07208019?term=medical+device